Biological indicators for /certified fixed orthodontic courses by Indian dent...Indian dental academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy provides dental crown & Bridge,rotary endodontics,fixed orthodontics,
Dental implants courses.for details pls visit www.indiandentalacademy.com ,or call
0091-9248678078
This document discusses microbiology activities related to sterility assurance for pharmaceutical products. It outlines the microbiological testing done on raw materials, processes, water systems, environments and finished products. This includes bioburden testing, pathogen testing, endotoxin testing, and sterility testing. It also discusses environmental monitoring programs for sterile facilities and aseptic filling areas. Key requirements outlined include pre-filtration bioburden limits, media fill qualifications, aseptic process simulations, and staff performance monitoring. Recent issues with increased out of limit environmental monitoring results are also summarized.
The document discusses validation of sterilization processes. It defines validation and sterilization. The commonly used sterilization methods are steam, dry heat, gas, and radiation. It then summarizes the validation process for each method. For steam sterilization, validation studies include qualification and calibration of equipment, heat distribution studies, and heat penetration studies. Dry heat validation involves air balance determination, heat distribution, and heat penetration studies. Gas sterilization validation is outlined for ethylene oxide and vapor hydrogen peroxide. Radiation sterilization validation focuses on determining the D-value of biological indicators.
Sterilization is necessary to destroy all microorganisms that could contaminate pharmaceuticals and pose a health risk. Since absolute sterility cannot be proven, sterility is defined probabilistically. The appropriate sterilization method depends on the product, contamination level, and production conditions. Common sterilization techniques include saturated steam, dry heat, filtration, and radiation; each must be validated for the specific product. Proper validation ensures sterility while preventing product deterioration.
Steam sterilization monitoring involves ensuring sterilized items are free from microorganisms. The document discusses several key aspects of steam sterilization monitoring including: (1) sterility assurance levels and D-values which define sterilization effectiveness, (2) common sterilization methods like steam, gamma radiation and hydrogen peroxide, (3) methods for monitoring sterilization like mechanical, chemical and biological indicators, and (4) levels of assurance including equipment, exposure, pack and load control through proper use of indicators and record keeping. Managing a positive biological indicator requires recalling implantable items, retesting the sterilizer, and putting it back in service only after three consecutive negative retests.
The draft USP chapters <1229> and <1229A> provide guidance on steam sterilization processes. <1229A> focuses specifically on steam sterilization of aqueous liquids, separating it from steam sterilization of parts due to differences in how overprocessing may impact product quality attributes. For liquid sterilization, a dual set of time-temperature parameters is established to assure both sterility and stability. The probability of a non-sterile unit calculation is shown to relate sterilization parameters to achieving the target 10-6 sterility assurance level.
Biological indicators for /certified fixed orthodontic courses by Indian dent...Indian dental academy
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and offering a wide range of dental certified courses in different formats.
Indian dental academy provides dental crown & Bridge,rotary endodontics,fixed orthodontics,
Dental implants courses.for details pls visit www.indiandentalacademy.com ,or call
0091-9248678078
This document discusses microbiology activities related to sterility assurance for pharmaceutical products. It outlines the microbiological testing done on raw materials, processes, water systems, environments and finished products. This includes bioburden testing, pathogen testing, endotoxin testing, and sterility testing. It also discusses environmental monitoring programs for sterile facilities and aseptic filling areas. Key requirements outlined include pre-filtration bioburden limits, media fill qualifications, aseptic process simulations, and staff performance monitoring. Recent issues with increased out of limit environmental monitoring results are also summarized.
The document discusses validation of sterilization processes. It defines validation and sterilization. The commonly used sterilization methods are steam, dry heat, gas, and radiation. It then summarizes the validation process for each method. For steam sterilization, validation studies include qualification and calibration of equipment, heat distribution studies, and heat penetration studies. Dry heat validation involves air balance determination, heat distribution, and heat penetration studies. Gas sterilization validation is outlined for ethylene oxide and vapor hydrogen peroxide. Radiation sterilization validation focuses on determining the D-value of biological indicators.
Sterilization is necessary to destroy all microorganisms that could contaminate pharmaceuticals and pose a health risk. Since absolute sterility cannot be proven, sterility is defined probabilistically. The appropriate sterilization method depends on the product, contamination level, and production conditions. Common sterilization techniques include saturated steam, dry heat, filtration, and radiation; each must be validated for the specific product. Proper validation ensures sterility while preventing product deterioration.
Steam sterilization monitoring involves ensuring sterilized items are free from microorganisms. The document discusses several key aspects of steam sterilization monitoring including: (1) sterility assurance levels and D-values which define sterilization effectiveness, (2) common sterilization methods like steam, gamma radiation and hydrogen peroxide, (3) methods for monitoring sterilization like mechanical, chemical and biological indicators, and (4) levels of assurance including equipment, exposure, pack and load control through proper use of indicators and record keeping. Managing a positive biological indicator requires recalling implantable items, retesting the sterilizer, and putting it back in service only after three consecutive negative retests.
The draft USP chapters <1229> and <1229A> provide guidance on steam sterilization processes. <1229A> focuses specifically on steam sterilization of aqueous liquids, separating it from steam sterilization of parts due to differences in how overprocessing may impact product quality attributes. For liquid sterilization, a dual set of time-temperature parameters is established to assure both sterility and stability. The probability of a non-sterile unit calculation is shown to relate sterilization parameters to achieving the target 10-6 sterility assurance level.
Validation of sterilization processes is important to establish that a specific sterilization method will consistently produce sterile products meeting quality standards. This document discusses various sterilization methods and their validation. It describes validating steam, dry heat, and gaseous sterilization processes. The key aspects covered for each method include qualification of equipment, calibration of temperature monitoring devices, heat distribution and penetration studies, and biological indicators to demonstrate sterility assurance.
This document discusses sterility testing methods according to various pharmacopoeias. It provides details on membrane filtration and direct inoculation methods for testing sterility of pharmaceutical products like injections and ophthalmic preparations. These methods are based on incubating the product samples in fluid thioglycollate medium and soybean-casein digest medium to check for microbial growth. Validation of sterility testing methods and interpretation of results are also covered.
The document discusses the history of hygiene practices in hospitals and their role in reducing infection rates. It outlines various sterilization methods used such as autoclaving and highlights the importance of monitoring effective sterilization. The document also discusses the factors that influence infection rates and the methods used for air surveillance in operating theaters, including settle plate counts and slit sampler tests.
This document discusses the validation of sterilization processes for sterile medicines. It defines sterility as a probability of less than 1 in 1 million of a container being contaminated. Sterilization methods discussed include moist heat, dry heat, ethylene oxide gas, radiation, and filtration. Validation of a sterilization process involves developing a protocol, calibrating instruments, developing sterilization cycles, and determining the necessary Fo value to achieve the required sterility assurance level based on the bioburden and most resistant organisms. Moist heat sterilization at 121°C for 15 minutes is provided as an example, which would achieve an Fo value of 15.
Contamination control and sterile manufacturingGeorge Wild
Microorganisms like bacteria, viruses, and fungal spores pose a contamination risk in sterile manufacturing. Cleanrooms with strict particle and airflow controls are needed. Personnel procedures aim to minimize shedding of microbes. Sterilization methods like heat aim to achieve a sterility assurance level of 1 in 1 million by killing all microbes or reducing their number below acceptable levels. Key factors in sterilization include the bioburden level and resistance of the most durable microorganism strain present.
This document provides information on autoclaving equipment and processes. It discusses the types of autoclaves, how they work, parameters for sterilization cycles, and methods for verification. Different loads and cycle conditions are tested to ensure proper heat distribution and sterilization throughout the chamber. Validation protocols outline installation, operational and performance qualification tests to demonstrate that the autoclave functions as intended.
The document describes procedures for testing the sterility of pharmaceutical products. It provides details on culture media, incubation temperatures, strains of test microorganisms, and the sterility test method. The key points are:
- Two common culture media are described for detecting bacteria (Fluid Thioglycollate Medium) and fungi/bacteria (Soybean-Casein Digest Medium).
- Samples are inoculated into media and incubated at specified temperatures, then examined for microbial growth which would indicate a failed sterility test.
- The sterility test method and number of samples tested depends on the type and amount of product available for testing.
This document provides an overview of HVAC system design for cleanroom facilities. It discusses the importance of indoor air quality in cleanrooms and outlines four fundamental rules for maintaining cleanroom environments. The document then describes key aspects of cleanroom HVAC system design, including filtration requirements, airflow patterns, temperature and humidity control, and monitoring systems. Maintaining proper pressurization, air exchange rates, and filtration are crucial for controlling airborne particle levels in cleanrooms.
This document discusses microbial contamination control in parenteral manufacturing. It outlines various layers of protection used, including terminal sterilization techniques like autoclaving. It also discusses aseptic processing and sources of contamination control strategies during aseptic manufacture. Other topics covered include blow-fill-seal technology, issues in sterilization by filtration, sterile prefilled syringes, process validation, hazard analysis and critical control points. Key sterilization techniques and the selection of appropriate test organisms to validate these processes are also summarized.
Sterilization Validation for Medical DevicesDocKetchum
Every medical device produced must be sterilized before being shipped to hospitals, doctors’ offices, and other medical locations.
Random samples of these devices must then be tested to be sure the sterilization kills disease causing microbes including bacteria, fungus, and spores in every device.
These are some of the most common ways that sterilization validation is performed.
The document discusses aseptic processing, which involves bringing together sterile products, containers, and closures that have been separately sterilized and assembling them in a highly controlled environment using specialized personnel and equipment. Key elements of aseptic processing include facility design and control, equipment sterilization and material handling, the aseptic processing itself, personnel training, process verification through media fills and environmental monitoring, finished product testing, and comprehensive documentation.
Clean spaces, also known as cleanrooms, are specially constructed enclosed spaces with tightly controlled environments to minimize particle and microbial contamination. They are classified based on the number of allowable particles per cubic meter of air and are used in applications like pharmaceuticals, semiconductors, aerospace and hospitals. Key aspects of cleanroom design include particle filtration and control, air pressure differentials between spaces, airflow patterns, and qualification testing to verify cleanroom conditions meet requirements. Pharmaceutical cleanrooms require additional considerations for barrier technologies, sterilization processes, and strict qualification of utilities and equipment.
Sterilization: F0 - what it means - how to calculate it - how to use itFedegari Group
F0: A technical note
- What it means
- How to calculate it
- How to use it for adjustment, control and
validation of moist-heat sterilization processes
The document discusses tunnel sterilizers, which are fully automated systems that use dry heat sterilization via forced convection of filtered air to sterilize and depyrogenate washed empty glassware used for parenteral drug products. The sterilization cycle is based on time and temperature parameters to reduce contamination to acceptable levels. Microorganism destruction follows linear kinetics, where the same percentage is destroyed each time interval at a given temperature. The sterilizer contains drying, sterilizing, and cooling zones, and uses HEPA filters and integrated sensors to control air flow and monitor temperatures throughout cycles.
This document discusses sterilization in the medical and pharmaceutical fields. It covers the importance of sterilization in preventing disease transmission and reinfection. Three main sterilization methods are described: physical (e.g. heat, radiation), chemical (e.g. ethylene oxide, filters), and mechanical (e.g. filters). The advantages and disadvantages of different sterilization instruments like autoclaves and gamma radiation chambers are explained. The document concludes by discussing future challenges in making sterilization more reliable, reusable, and cost-effective.
Aseptic Area and Microbial Control. - Pharmaceutical Microbiology (SYBpharm) ...Kiran Shinde
Prof.Mr.Kiran K. Shinde (M.Pharm), Assistant professor (VNIPRC)
Pharmaceutical microbiology (Second year b.pharm) (3rd semester)
Introduction to Aseptic area & room
Designing of Aseptic Room
Laminar Airflow Equipment
Sources of Contamination & Method of Prevention
Classification of Aseptic Area-Room
Testing of Clean Aseptic Room
Microbial Impacts on Pharma Products & Cross ContaminationSrinath Sasidharan
This document discusses microbial contamination and cross-contamination in pharmaceutical manufacturing. It defines cross-contamination as the presence of small quantities of other products manufactured in the same premises. The types of contamination are physical, chemical, and biological from sources like personnel, equipment, and environment. Cross-contamination can be minimized through personnel procedures, adequate facilities, closed production systems, cleaning validation, and proper air pressure differentials. Special attention needs to be given to prevent cross-contamination of beta-lactam drugs like penicillin which can cause allergic reactions in sensitive patients. FDA regulations require dedicated areas for their production to prevent sensitization issues. Personnel hygiene and housekeeping are important to control contamination.
Cross contamination in Pharmaceuticals - by Jitendra J Jagtapjitendrajagtap1986
The document discusses cross contamination in pharmaceutical manufacturing. It states that the manufacturing environment is critical for product quality and can impact light, temperature, humidity, air movement and microbial and particulate contamination. Poorly designed or maintained air handling systems, inadequate cleaning procedures, and insufficient personnel and equipment procedures can lead to cross contamination originating from the environment, operators or equipment. Cross contamination can be minimized through skilled personnel, adequate facility design, closed production systems, validated cleaning procedures, and appropriate air pressure differentials in heating, ventilation and air conditioning systems.
The document discusses the validation of various sterilization methods and water supply systems used in pharmaceutical manufacturing. It provides details on:
1. The key properties of sterile products and various sterilization methods like heat, gas, radiation.
2. The validation process for steam, dry heat and ethylene oxide sterilization including qualification of equipment and instruments, heat distribution studies, biological indicators, and establishing a monitoring program.
3. Types of water systems used, water treatment techniques, equipment components, design considerations for storage and distribution, and the concept of validation involving engineering design, operating procedures, maintenance and testing under all conditions.
This document provides an overview of sterilization including:
- Definitions of key terms like sterilization, antiseptic, bacteriostatic, and viable
- Classification of sterilization methods into terminal and non-terminal processes
- Parameters used to measure sterilization effectiveness like D-value and z-value
- Methods of controlling microorganisms through physical sterilization techniques like heat and radiation or chemical sterilization agents
- Guidance on sterilization from regulatory bodies like the FDA
- Conclusions on the importance of sterilization in various applications like pharmaceuticals and healthcare
Validation of sterilization processes is important to establish that a specific sterilization method will consistently produce sterile products meeting quality standards. This document discusses various sterilization methods and their validation. It describes validating steam, dry heat, and gaseous sterilization processes. The key aspects covered for each method include qualification of equipment, calibration of temperature monitoring devices, heat distribution and penetration studies, and biological indicators to demonstrate sterility assurance.
This document discusses sterility testing methods according to various pharmacopoeias. It provides details on membrane filtration and direct inoculation methods for testing sterility of pharmaceutical products like injections and ophthalmic preparations. These methods are based on incubating the product samples in fluid thioglycollate medium and soybean-casein digest medium to check for microbial growth. Validation of sterility testing methods and interpretation of results are also covered.
The document discusses the history of hygiene practices in hospitals and their role in reducing infection rates. It outlines various sterilization methods used such as autoclaving and highlights the importance of monitoring effective sterilization. The document also discusses the factors that influence infection rates and the methods used for air surveillance in operating theaters, including settle plate counts and slit sampler tests.
This document discusses the validation of sterilization processes for sterile medicines. It defines sterility as a probability of less than 1 in 1 million of a container being contaminated. Sterilization methods discussed include moist heat, dry heat, ethylene oxide gas, radiation, and filtration. Validation of a sterilization process involves developing a protocol, calibrating instruments, developing sterilization cycles, and determining the necessary Fo value to achieve the required sterility assurance level based on the bioburden and most resistant organisms. Moist heat sterilization at 121°C for 15 minutes is provided as an example, which would achieve an Fo value of 15.
Contamination control and sterile manufacturingGeorge Wild
Microorganisms like bacteria, viruses, and fungal spores pose a contamination risk in sterile manufacturing. Cleanrooms with strict particle and airflow controls are needed. Personnel procedures aim to minimize shedding of microbes. Sterilization methods like heat aim to achieve a sterility assurance level of 1 in 1 million by killing all microbes or reducing their number below acceptable levels. Key factors in sterilization include the bioburden level and resistance of the most durable microorganism strain present.
This document provides information on autoclaving equipment and processes. It discusses the types of autoclaves, how they work, parameters for sterilization cycles, and methods for verification. Different loads and cycle conditions are tested to ensure proper heat distribution and sterilization throughout the chamber. Validation protocols outline installation, operational and performance qualification tests to demonstrate that the autoclave functions as intended.
The document describes procedures for testing the sterility of pharmaceutical products. It provides details on culture media, incubation temperatures, strains of test microorganisms, and the sterility test method. The key points are:
- Two common culture media are described for detecting bacteria (Fluid Thioglycollate Medium) and fungi/bacteria (Soybean-Casein Digest Medium).
- Samples are inoculated into media and incubated at specified temperatures, then examined for microbial growth which would indicate a failed sterility test.
- The sterility test method and number of samples tested depends on the type and amount of product available for testing.
This document provides an overview of HVAC system design for cleanroom facilities. It discusses the importance of indoor air quality in cleanrooms and outlines four fundamental rules for maintaining cleanroom environments. The document then describes key aspects of cleanroom HVAC system design, including filtration requirements, airflow patterns, temperature and humidity control, and monitoring systems. Maintaining proper pressurization, air exchange rates, and filtration are crucial for controlling airborne particle levels in cleanrooms.
This document discusses microbial contamination control in parenteral manufacturing. It outlines various layers of protection used, including terminal sterilization techniques like autoclaving. It also discusses aseptic processing and sources of contamination control strategies during aseptic manufacture. Other topics covered include blow-fill-seal technology, issues in sterilization by filtration, sterile prefilled syringes, process validation, hazard analysis and critical control points. Key sterilization techniques and the selection of appropriate test organisms to validate these processes are also summarized.
Sterilization Validation for Medical DevicesDocKetchum
Every medical device produced must be sterilized before being shipped to hospitals, doctors’ offices, and other medical locations.
Random samples of these devices must then be tested to be sure the sterilization kills disease causing microbes including bacteria, fungus, and spores in every device.
These are some of the most common ways that sterilization validation is performed.
The document discusses aseptic processing, which involves bringing together sterile products, containers, and closures that have been separately sterilized and assembling them in a highly controlled environment using specialized personnel and equipment. Key elements of aseptic processing include facility design and control, equipment sterilization and material handling, the aseptic processing itself, personnel training, process verification through media fills and environmental monitoring, finished product testing, and comprehensive documentation.
Clean spaces, also known as cleanrooms, are specially constructed enclosed spaces with tightly controlled environments to minimize particle and microbial contamination. They are classified based on the number of allowable particles per cubic meter of air and are used in applications like pharmaceuticals, semiconductors, aerospace and hospitals. Key aspects of cleanroom design include particle filtration and control, air pressure differentials between spaces, airflow patterns, and qualification testing to verify cleanroom conditions meet requirements. Pharmaceutical cleanrooms require additional considerations for barrier technologies, sterilization processes, and strict qualification of utilities and equipment.
Sterilization: F0 - what it means - how to calculate it - how to use itFedegari Group
F0: A technical note
- What it means
- How to calculate it
- How to use it for adjustment, control and
validation of moist-heat sterilization processes
The document discusses tunnel sterilizers, which are fully automated systems that use dry heat sterilization via forced convection of filtered air to sterilize and depyrogenate washed empty glassware used for parenteral drug products. The sterilization cycle is based on time and temperature parameters to reduce contamination to acceptable levels. Microorganism destruction follows linear kinetics, where the same percentage is destroyed each time interval at a given temperature. The sterilizer contains drying, sterilizing, and cooling zones, and uses HEPA filters and integrated sensors to control air flow and monitor temperatures throughout cycles.
This document discusses sterilization in the medical and pharmaceutical fields. It covers the importance of sterilization in preventing disease transmission and reinfection. Three main sterilization methods are described: physical (e.g. heat, radiation), chemical (e.g. ethylene oxide, filters), and mechanical (e.g. filters). The advantages and disadvantages of different sterilization instruments like autoclaves and gamma radiation chambers are explained. The document concludes by discussing future challenges in making sterilization more reliable, reusable, and cost-effective.
Aseptic Area and Microbial Control. - Pharmaceutical Microbiology (SYBpharm) ...Kiran Shinde
Prof.Mr.Kiran K. Shinde (M.Pharm), Assistant professor (VNIPRC)
Pharmaceutical microbiology (Second year b.pharm) (3rd semester)
Introduction to Aseptic area & room
Designing of Aseptic Room
Laminar Airflow Equipment
Sources of Contamination & Method of Prevention
Classification of Aseptic Area-Room
Testing of Clean Aseptic Room
Microbial Impacts on Pharma Products & Cross ContaminationSrinath Sasidharan
This document discusses microbial contamination and cross-contamination in pharmaceutical manufacturing. It defines cross-contamination as the presence of small quantities of other products manufactured in the same premises. The types of contamination are physical, chemical, and biological from sources like personnel, equipment, and environment. Cross-contamination can be minimized through personnel procedures, adequate facilities, closed production systems, cleaning validation, and proper air pressure differentials. Special attention needs to be given to prevent cross-contamination of beta-lactam drugs like penicillin which can cause allergic reactions in sensitive patients. FDA regulations require dedicated areas for their production to prevent sensitization issues. Personnel hygiene and housekeeping are important to control contamination.
Cross contamination in Pharmaceuticals - by Jitendra J Jagtapjitendrajagtap1986
The document discusses cross contamination in pharmaceutical manufacturing. It states that the manufacturing environment is critical for product quality and can impact light, temperature, humidity, air movement and microbial and particulate contamination. Poorly designed or maintained air handling systems, inadequate cleaning procedures, and insufficient personnel and equipment procedures can lead to cross contamination originating from the environment, operators or equipment. Cross contamination can be minimized through skilled personnel, adequate facility design, closed production systems, validated cleaning procedures, and appropriate air pressure differentials in heating, ventilation and air conditioning systems.
The document discusses the validation of various sterilization methods and water supply systems used in pharmaceutical manufacturing. It provides details on:
1. The key properties of sterile products and various sterilization methods like heat, gas, radiation.
2. The validation process for steam, dry heat and ethylene oxide sterilization including qualification of equipment and instruments, heat distribution studies, biological indicators, and establishing a monitoring program.
3. Types of water systems used, water treatment techniques, equipment components, design considerations for storage and distribution, and the concept of validation involving engineering design, operating procedures, maintenance and testing under all conditions.
This document provides an overview of sterilization including:
- Definitions of key terms like sterilization, antiseptic, bacteriostatic, and viable
- Classification of sterilization methods into terminal and non-terminal processes
- Parameters used to measure sterilization effectiveness like D-value and z-value
- Methods of controlling microorganisms through physical sterilization techniques like heat and radiation or chemical sterilization agents
- Guidance on sterilization from regulatory bodies like the FDA
- Conclusions on the importance of sterilization in various applications like pharmaceuticals and healthcare
1. A study examined the effectiveness of different cleaning methods for laryngoscope handles in reducing bacterial contamination.
2. Laboratory experiments showed that wipes containing chlorhexidine and alcohol were highly effective at eliminating bacteria immediately after cleaning and provided residual sterilization for up to 24 hours.
3. An audit of laryngoscope handles in a hospital found high levels of bacterial contamination before changing cleaning protocols, but contamination was significantly reduced after implementing the use of chlorhexidine wipes between patients.
This document discusses sterile products and clean room classifications. Sterile products must be free from microorganisms and pyrogens. They include parenterals, ophthalmics, and irrigation fluids. Several factors are important for sterile compounding including clean facilities, trained personnel, and sterilization/stability principles. Clean rooms are classified based on particulate levels, with grades A through D (or classes 100 through 100,000) used in pharmaceutical facilities. Grade A/class 100 areas are needed for high-risk aseptic operations.
The document outlines key topics in environmental microbiology including the roles of microorganisms like algae, fungi, and bacteria in the environment. It discusses optimal conditions for microbial growth and describes microbial growth curves. It also addresses microorganisms in various settings like water, food, waste, soil and their roles in nutrient cycles. The document concludes by covering management of microorganisms in healthcare facilities, universal precautions, disinfection techniques, and sterilization methods.
This document discusses various methods for assessing the efficacy of disinfectants and sterilization processes, including physical, chemical, and biological indicators. The turbidimetric method uses turbidity measurements after a short incubation period to assess the ability of disinfectants and antibiotics to inhibit bacterial growth. Chemical indicators monitor sterilization processes by undergoing color changes in response to heat, steam, or radiation. Biological indicators use bacterial spores to validate the sterilization of equipment and facilities.
This document provides definitions and information about sterilization including:
- Definitions of sterilization, antiseptic, bacteriostatic, bactericidal, viable, disinfection, and related terms.
- Classification of sterilization processes as terminal or non-terminal and by mechanism (physical, chemical).
- Parameters used to measure sterilization effectiveness like D-value and Z-value.
- Methods of controlling microorganisms including physical methods like heat and radiation sterilization and chemical methods using biocides.
- Descriptions of common sterilization equipment like autoclaves and hot air ovens.
2021 laboratory diagnosis of infectious diseases dr.ihsan alsaimarydr.Ihsan alsaimary
2021 laboratory diagnosis of infectious diseases
dr. ihsan alsaimary
university of basrah - college of medicine- DEPARTMENT OF MICROBIOLOGY
POBOX 696 ASHAR
BASRAH 42001
IRAQ
The document discusses sterilization and disinfection methods. It defines sterilization as destroying all microorganisms and disinfection as destroying vegetative microorganisms. The two main sterilization methods are physical (heat, filtration, radiation) and chemical agents. Heat sterilization can be dry heat or moist heat via autoclaving, boiling, or tyndallization. Filtration and radiation can also sterilize. Common chemical disinfectants are phenol, alcohols, halogens, heavy metals, formaldehyde and ethylene oxide gases, and soaps.
Hospital Acquired Infections/Health care associated infections/Nosocomial infection .
More useful for MBBS ,PG (MD/MS) Students to get a brief idea about HAI.
This report describes the process of establishing a second WHO International Standard for Bleomycin complex A2/B2. Material was donated by a manufacturer and processed by EDQM. 8 laboratories participated in a study where they estimated potencies of the candidate material using microbiological assays. Statistical analysis of the results showed the candidate batch was homogeneous and stable. It is proposed that the second WHO International Standard for Bleomycin complex A2/B2 be assigned a potency of 12,500 IU/vial.
This document describes the process for collecting and analyzing blood cultures. Blood cultures involve injecting blood samples into bottles containing culture media to detect microorganisms. The process involves drawing blood via venipuncture, decontaminating bottle tops, applying antiseptic to the skin, inoculating bottles, mixing, labeling, and sending samples for analysis. Automated blood culture analyzers use techniques like fluorescence, colorimetry, or pressure changes to detect microorganism growth and provide results. Factors like adequate sample volume, contamination prevention, and analyzer features should be considered when purchasing a system.
1) Sterilization and disinfection have a long history dating back to ancient Greek and Roman times when practices like boiling water and hand washing were used.
2) In the 1800s, figures like Semmelweiss, Nightingale, and Lister advanced practices of sterilization and antisepsis in hospitals and operating rooms which reduced infection rates and mortality.
3) Modern sterilization practices in operating rooms focus on preventing surgical site infections through strict protocols for cleaning, disinfection, air filtration, sterile techniques, and care of equipment, personnel, and facilities.
White paper 2020: G-CON's Transmissible Disease Defense UnitsBrittany Berryman
This white paper discusses the use of flexible, mobile biocontainment and test units to prevent the spread of transmissible diseases. Transmissible diseases are no longer scarce and geographically limited to a location, but are becoming a more frequent occurrence, spreading rapidly due to rising populations and modern travel capability. Additionally, infectious diseases are now thriving in regions previously unsuitable for spread due to unfavorable climate and environmental conditions. Both types of diseases, therefore, have become a real threat for the entire global population.
This document discusses the use of disposable microfiber cloths (D-MFCs) for cleaning clinical equipment at a large metropolitan health service. A study found that D-MFCs and reusable microfiber cloths were able to remove fluorescent markings and viable bacteria like vancomycin-resistant Enterococcus, while standard paper towels and detergent wipes were not as effective. The health service was then able to transition to using D-MFCs for cleaning sensitive equipment that could not be disinfected with hypochlorite solution. This provided a superior cleaning system and allowed all clinical equipment to be used, even for patients infected or colonized with multidrug-resistant organisms.
Infection Control Guidelines for Respiratory Therapy Services[compatibility m...drnahla
Infection Control Guidelines for Respiratory Therapy Services
Infection Prevention in Respiratory Therapy Services
Dr. NAHLA ABDEL KADERوMD, PhD.
INFECTION CONTROL CONSULTANT, MOH
INFECTION CONTROL CBAHI SURVEYOR
Infection Control Director, KKH.
5.1.3. Efficacy of antimicrobial preservation (EP 5.0)Guide_Consulting
Salah Satu Referensi Yang Digunakan Dalam One Day Seminar "Preservative Effectiveness Validation" 04 Desember 2014.
Detail : info@traininglaboratorium.com
Quality Control Of Parenteral PreparationsQurat Ul Ain
This document provides information about quality control of parenterals. It discusses key terms related to parenterals and routes of administration such as intravenous, intramuscular, and subcutaneous. The document outlines quality control tests performed on parenterals including leaker tests, pyrogen tests, particulate tests, sterility tests, and uniformity of content tests. Specific procedures for leaker tests and pyrogen tests using the LAL assay are described. The importance of quality control in ensuring parenterals are free from contamination and meet defined quality standards is also emphasized.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
1. 1
University hospital of Ulm
2
Hochschule Furtwangen University
Point Source Infections Related with Heater Cooler Units (HCU)
- an overview about a preventive method to decrease the bioburden
Albrecht G.1
, Aydogdu F. 1
, Sajgo S. 1
, Hildebrandt U. 2
University clinic of Ulm, August 2017, Department of Cardiothoracic and Vascular surgery-
Cardiovascular perfusion technologies,
Ulm, Germany
Abstract
According to the safety prescriptions of the FDA and the
manufacturer of HCU, Liva Nova PLC (formerly Sorin Group
Germany GmbH), the Heater- Cooler- Units were identified as
a source of Mycobacterium chimaera (1), (2). In Switzerland,
two patients were infected with NTM (Non- Tuberculosis-
Mycobacteria) by cardio-thoracic surgery receiving a
prosthetic valve implantation and with lethal ending (3).
By this observation special awareness was taken into
consideration as well as for the manufacturer as for health care
providers, surgeons, hospital staff and last but not least for the
patient.
Key words: Heater-Cooler- Unit (HCU), P. aeruginosa, M.
chimaera, disinfection and cleaning of HCU, micro PES filter
I. INTRODUCTION
An essential part of extracorporeal circuits is a Heater-Cooler-
Unit (HCU), which either cools or warms the blood
temperature during Cardiopulmonary Bypass surgeries. The
HCU from the manufacturer Sorin 3 T includes three water
tanks, which are filled with disinfected water and pass via
external hose system through an oxygenator by a heat
exchanger. By this way it is possible to cool or warm the
blood temperature during cardiothoracic surgeries (4).
While the use of HCU in extracorporeal circuits is unalterable,
they were reported 5 incidents with infections alone Europe,
since 2008 (5). In Switzerland for the first timing in 2011 an
infection was observed with M. chimaera by a contaminated
Heater Cooler- Unit (HCU). Also earlier investigations on a
national level revealed contamination of HCU in 16 out of 78
cardio-thoracic treatment centers (5). Besides of M. chimaera
there were additionally detected P. aeruginosa, L.
pneumophilae, S. maltophilia and mushrooms. The trigger of
this slow growing incident is referable to the responsible
germ, called mycobacteria chymaera. Whereas the germ is
benign in normal environment, it is in a clinical context
getting a potential risk for infections, especially in patients
with immunosupressed status, who were undergone a
cardiothoracic surgery (6).
The purpose of this current work was to detect the source of
the infections associated with Heater-Cooler-Units during
Cardiopulmonary bypass. Furthermore, this current work will
present preventive methods, like disinfection and cleaning of
the Heater- Cooler- Units, including a filter with a pore size of
0.2 µm, which can reduce or in the best case eliminate the
transmission of Mycobacteria into the chirurgical field.
II. MATERIAL AND METHOD
Referring to the safety notices of Liva Nova from July 2014,
which was firstly reported of infections with the germ M.
chimaera, strongly disinfection methods were implemented.
For minimizing a potential risk for possibly contamination of
HCU with M. chymaera there should be observed the
guidelines for product care and maintenance. Health care
providers should take care for additional sources of infection
risk.
The task of this current work was thereby to determine the
efficacy of an additional component- a micro pore size filter,
certified in 2009, which retains the contamination in 3 T HCU
circuits as soon as the quality of disinfection procedures.
Besides of mentioned prophylactic recommendations like
product care and maintenance, an onset of a MicroPES filter
was applicated as an extra precaution. The evaluated filter
consists of a hydrophil polyethersulfon- a polymermembrane
with a permeability of 0.2 µm and a surface area of 0.6 m². The
maximum operating pressure accounts to 1 bar and the
maximum operating temperature to 45 degrees (7). The filter
was installed in HCU between the outlet circuit 1 and outlet
circuit 2 (4).
To come up to the standard of the university clinic of Ulm:
Routine tests of sampling tests from the tanks were checked
and performed by the microbiology laboratory institute of the
university of Ulm. The protocol unit includes an investigation
of the sampling tests, which were obtained from the tanks of
the heater cooler unit – pre filter and post filter. By this way it
is possible to identify the bioburden in each Heater Cooler
Unit. In addition to the effortful disinfection procedure at
Heater- Cooler- Units (HCU) the chief aim is to integrate an
additional component, which eliminates in the best case the
bioburden.
2. III. RESULTS
To get real specifications of the efficacy from integrated filter,
this retrospective investigation was separated in three phases
(8).
Stage 1: As a starting point screening the efficacy of the filter,
for usage of 3T Heater Cooler Units in the university hospital
must be considered regarding to the quantity of
microorganisms. The sampling for tests are taken from the
tanks for determination of the involved microorganisms. An
examination in the microbiological institute of Ulm confirmed
the detection of P. aeruginosa. The results are shown in chart
1.
chart1: Results of detected microorganisms, examined in the
Institute for Microbiology at the University hospital of Ulm
Stage 2: At this stage of assignment for elimination the
bioburden, cleaning and disinfection methods were performed
all 7 days. Additionally new PVC (polyvinyl chloride) hoses
were replaced, the Micro PES 2F PH was integrated and hansa
clutches were disinfected for 24 hours with disinfectant
solution.
According to the operating instructions for disinfection and
cleaning of Heater Cooler Units of Liva Nova, the Heater
Cooler Units were filled with 20 liters filtered, potable water
and swilled with 80 ml Peresal for 10 minutes. After chemical
flushing twice repeated flushing cycles were realised (10
minutes per Heater Cooler Unit).
Finally, as predefined from the manufacturer, 250 ml
hydrogen peroxide was stuffed in the water tank and 20 l
filtered water. An additional component, a micro pore size
filter, which should guarantee an effective retention of
microorganisms, was applicated at this stage of investigation.
The results from the effectiveness of the integrated filter are
shown in chart 2: The retention of P. aeruginosa is
considerably larger as in the case of absence of the filter.
chart 2: Results of remained P. aeruginosa with integrated
filter, examined in the Institut for Microbiology at the
University hospital of Ulm
Stage 3: The procedure for disinfection and cleaning of HCU
was conducted again as described by stage 2. For safety
precaution of colonization with microorganisms, the operating
temperature of HCU was adjust to 20° degree. In accordance
with DIN 16266 there were no qualitative and quantitative
detection of Mycobacteria or P. aeruginosa- naccording to the
inspection report from the Institute for Microbiology in the
university hospital of Ulm (9).
IV. DISCUSSION
After customer safety advisor notices from the manufacturer
LivaNova, firstly reported in 2014, a new origin of potential
risk of infection for immunosupressed patients were identified.
The chief aim of this current work was, ideally, to degerm all
three HCU, which are employed in our university clinic.
In this way it was necessary for an implementation of
optimized procedures for product care and maintenance in
HCU to decrease the bioburden. The manufacturer published
since 2014 safety arrangements continuously and
measurements for decreasing the bioburden. In our
investigation we have tested the efficacy of the conventional
Laboratory
number
source of sample-
taking (OR-
operating room)
microbiological
findings
[CFU/100 ml]
operating room 6
2726 HCU OR 6 - tank >106
P. aeruginosa
2727 HCU OR 6- post
hose system
>106
P. aeruginosa
operating room 5
2728 HCU OR 5- tank >106
P. aeruginosa
2729 HCU OR 5- post
hose system
>106
P. aeruginosa
3002 HCU OR 5- post
filter
>106
P. aeruginosa
3003 HCU OR 6- post
filter
>106
P. aeruginosa
Laboratory
number
source of sample-
taking
microbiological
findings
[CFU/100 ml]
2726 HCU 1 -tank 100 CFU
P. aeruginosa
2727 HCU 1- post filter 20 CFU
P. aeruginosa
2728 HCU 2 - tank no quantitative and
qualitative detection
of P. aeruginosa
2729 HCU 2 – post filter no quantitative and
qualitative detection
of P. aeruginosa
3002 HCU 3 - tank >106
P. aeruginosa
3003 HCU 3 – post filter no quantitative and
qualitative detection
of P. aeruginosa
3. disinfection method and an additional component, a micro
pore size filter, which have passed in an in vitro evaluation
from the producer Membrana GmbH the bacterial challenge
test (10). At the stage 1 of our investigation, all three Heater
Cooler Units were generously contaminated with
P.aeruginosa. Same results were obtained in spite of
application the filter. This was primarily due to contaminated
external hose systems, which were replaced at the stage 2. In
the second phase of our investigation, at stage 2, adjusted heat
transfer fluids were obtained with a 100 CFU per 100 ml. This
quantity is equivalent to drinking water ordinance.
Consequently, our research confirmed the clinical efficacy of
the applied filter.
Currently there are no opportunities given, which retain the
contamination without any external components (10). The
extensive disinfection method is a good basis for cleaning the
water tanks, but based on our investigation at the stage 1 of
our evaluation, it is not clearly effective to eliminate
microorganisms. Especially, P. aeruginosa couldn’t retained
with the disinfection and cleaning methods of HCU.
Considering that the structural conditions in water tanks of
HCU there is not a planar area (12). Therefore, the problem of
germ load is preexisting and generate an appropriate
disinfection procedure. Whereas the attempt in stage 2 of our
evaluation, the implementation of the micro pore size filter
presented a high retention power of microorganisms. For safe
and reliable operation of the Membrana micro pore size PES-
filter, the time interval of 7 days should be observed.
REFERENCES
1. Food and Drug Adminstration (FDA) [Online] [Cited: 13 Mai
2016]
http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/U
CM520191.htm
2. Liva Nova (Sorin Group GmbH- Munich)
Customer Letter US 3 T, [Online] [Cited: December 2016]
http://www.livanova.sorin.com/products/cardiac-
surgery/perfusion/hlm/3t
3. Achermann, Rössle, Hoffmann, Deggim, Kuster, Zimmermann,
Bloemberg, Hombach, Hasse. Prosthetic Valve Endocarditis and
Bloodstream Infection Due to Mycobacterium chimaera. Journal
of Clinical Microbiology, June 2013, Vol. 51, Number 6
(p.1769-1773)
4. Operating Instructions, Sorin Group USA, Firmware Version
02/2015 [Online- PDF- document], capture 3 - 7, System and
technical descriptions
www.sorineifu.com/PDFs/45-91-45USA_C.PDF
5. Haller, Höller, Jacobshagen, Hamouda, M Abu Sin, Monnet ,
Plachouras, Eckmanns
Contamination during production of heater-cooler units by
Mycobacterium chimaera potential cause for invasive
cardiovascular infections: results of an outbreak investigation in
Germany, April 2015 to February 2016, Eurosurveillance,
Volume 21, Issue 17, 28 April 2016
6. Trudzinski, , Kamp, Hennemann, Muellenbach,,
Reischl,
Gärtner, Wilkens, Bals, Herrmann, Lepper, Becker Clinical
implications of Mycobacterium chimaera detection in
thermoregulatory devices used for extracorporeal membrane
oxygenation (ECMO), Germany, 2015 to 2016,
Eurosurveillance, Volume 21, Issue 46, 17 November 2016
7. Manual Micro PES 2 F PH Filter, [Online] [Cited: July 2016]
http://www.membrana.com/industrial-filtration/industrial-
filtration-data/industrial-filtration-
documents/micropes%C2%AE-membranes/micropes%C2%AE-
2f-ph/micropes_2f_ph_0812.aspx
8. Der Einsatz von MicroPES-Membranfilter zur Reinigung der
Wärmeträgerflüssigkeit von Hypo- Hyperthermiegeräten –
Stefan Sajgo, Upragradekurs zur Erlangung des ECCP,
Universitätsklinik Ulm, Kardiotechnik
9. H. von Baum et al, Mikrobiologisches Institut der
Universitätsklinik Ulm, Protokoll für die Untersuchung von
quantitativen und qualitativen Mykobakterien in
Hypothermiegeräten.
10. Dura PES 200® Data Sheet, Keimretention (Brevundimonas
diminuta) in Micro PES 2 F PH Filter, [Online] [Cited: 17 July
2017]
11. Keimfreier Heater- Cooler- Unit- Mission impossible? Congress
of cardiovascular perfusion technologies: Deutsche Gesellschaft
für Kardiotechnik, Weimar 25.11. – 27.11.2017, Presentation-
Martin Schmitt, Firma Liva Nova GmbH
12. Liva Nova GmbH, photographic image oft he tanks in HCU-
Exposure with biofilm in tanks of Heater-Cooler- Units ,
Operation and Maintenance, Technician- Andreas Wex,
September 2017